Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Episurf Medical AB Company Overview 4

Episurf Medical AB Company Snapshot 4

Episurf Medical AB Pipeline Products and Ongoing Clinical Trials Overview 4

Episurf Medical AB – Pipeline Analysis Overview 7

Episurf Medical AB - Key Facts 7

Episurf Medical AB - Major Products and Services 8

Episurf Medical AB Pipeline Products by Development Stage 9

Episurf Medical AB Ongoing Clinical Trials by Trial Status 11

Episurf Medical AB Pipeline Products Overview 13

Episealer Ankle Implant 13

Episealer Ankle Implant Product Overview 13

Episealer Condyle Solo 14

Episealer Condyle Solo Product Overview 14

Episealer Condyle Solo Clinical Trial 15

Episealer Femoral Twin 16

Episealer Femoral Twin Product Overview 16

Episealer Trochlea Solo 17

Episealer Trochlea Solo Product Overview 17

Episealer Trochlea Solo Clinical Trial 18

Episurf Medical AB - Key Competitors 19

Episurf Medical AB - Key Employees 20

Episurf Medical AB - Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 22

Episurf Medical AB, Recent Developments 22

Jul 06, 2018: New Japanese patent approval for Episurf Medical 22

Jun 28, 2018: Clinical results from the use of Episealer to be presented at the annual meeting of the Swedish Orthopaedic Association 22

Jun 28, 2018: Episurf Medical submits IDE application to the US FDA for the Episealer knee implant 22

Jun 26, 2018: Further clinical results from the use of Episealer to be presented at the annual meeting of the German Knee Society 22

Jun 25, 2018: Episealer clinical results accepted for presentation at the German Knee Society Congress 23

May 23, 2018: Episurf Medical continues preparations for its US IDE study by appointing Dr Michael A Kelly as special study advisor 23

May 22, 2018: European patent approval for Episurf Medical’s individualised surgical instruments 23

May 14, 2018: Episurf Medical: Management group changes 23

May 02, 2018: Promising clinical results from use of Episealer accepted for presentation at the 35th AGA Congress in Austria 24

Apr 27, 2018: Episurf: Interim Report 1 January – 31 March 2018 24

Appendix 25

Methodology 25

About GlobalData 28

Contact Us 28

Disclaimer 28

Summary

Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. The company offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, Episealer Trochlea Solo, Episealer Trochlea Twin, Epiguide and toolkit; and MRI protocol. Episurf Medical’s Episealer Condyle Solo is a patient-specific resurfacing implant intended for the knee condyle for the treatment of localized cartilage and underlying bone defects. The company offers patient-specific joint resurfacing implants for providing pain relief and mobility restoration. Its products are used in repair of localized cartilage and underlying bone defects in knees, trochlea area in the knee, and other condyles and trochlea areas. Episurf Medical is headquartered in Stockholm, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Episurf Medical AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company